The K2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts.

Prolongation of cardiac action potentials is considered antiarrhythmic in the atria but can be proarrhythmic in ventricles if the current carried by Kv11.1-channels (I) is inhibited. The current mediated by K2-channels, I, is considered a promising new target for treatment of atrial fibrillation (AF). Selective inhibitors of I (dofetilide) and I (AP14145) were used to compare the effects on ventricular and atrial repolarization. Ondansetron, which has been reported to be a potent blocker of both I and I, was included to examine its potential atrial antiarrhythmic properties. The expression of K2- and K11.1-channels in the guinea pig heart was investigated using quantitative polymerase chain reaction (qPCR). Whole-cell patch clamp technique was used to investigate the effects of dofetilide, AP14145, and ondansetron on I and/or I. The effect of dofetilide, AP14145, and ondansetron on atrial and ventricular repolarization was investigated in isolated hearts. A novel atrial paced guinea pig model was further validated using AP14145 and dofetilide. AP14145 increased the atrial effective refractory period (AERP) without prolonging the QT interval with Bazett's correction for heart rate (QTcB) both and . In contrast, dofetilide increased QTcB and, to a lesser extent, AERP in isolated hearts and prolonged QTcB with no effects on AERP in the guinea pig model. Ondansetron did not inhibit I, but did inhibit I . Ondansetron prolonged ventricular, but not atrial repolarization . I inhibition by AP14145 selectively increases atrial repolarization, whereas I inhibition by dofetilide and ondansetron increases ventricular repolarization to a larger extent than atrial repolarization.